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The optometric implications of the AIDS virus 
Abstract 
This article is designed as an informative and comprehensive literature review about the Human 
Immunodeficiency Virus(HIV) that causes the Acquired Immunodeficiency Syndrome(AIDS) and the 
implications of AIDS on the practice of optometry. This article is divided into three sections: the first 
section describes the effect of the virus upon the body's immune system and reports current statistics 
regarding the spread and mortality rate of AIDS. The second section is a practitioner's guide on how to 
detect the particular signs and symptoms of the more common ocular diseases affecting AIDS patients. 
The third section describes the transmissibility of the HIV from patient to practitioner, or from patient to 
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ABSTRACT 
This article is designed as an informative and comprehensive literature 
review about the Human Immunodeficiency Virus(HIV) that causes the 
Acquired Immunodeficiency Syndrome(AIDS) and the implications of AIDS 
on the practice of optometry. This article is divided into three sections: 
the first section describes the effect of the virus upon the body's immune 
system and reports current statistics regarding the spread and mortality 
rate of AIDS. The second section is a practitioner's guide on how to detect 
the particular signs and symptoms of the more common ocular diseases 
affecting AIDS patients. The third section describes the transmissibility 
of the HIV from patient to practitioner, or from patient to patient via the 
optometric office. 
As primary health care practitioners, we need to be informed, as 
completely and accurately as possible about the virus that causes 
Acquired Immune Deficiency Syndrome(AIDS) and the impact of the disease 
AIDS in our patients and on our practice. 
The virus causing AIDS is currently denoted as the Human 
Immunodeficiency Virus(HIV). Previously, other commonly utilized names 
for the same virus have been the Human T-cell Lymphotropic(Leukemia) 
Virus Type-III(HTLV-111) or the Lymphadenopathy Associated Virus(LAV). 
This virus can severely devastate the body's immune system, making the 
fight against infectious diseases for the AIDS patient exceedingly 
difficult. There is a 90 percent mortality rate for AIDS patients who were 
diagnosed in 1981 as having AIDS, and the cumulative mortality rate of all 
diagnosed AIDS patients(from January 1981 - Jan. 1987) is 57 percent.1 
The range of manifestations of HIV infection may include no signs or 
symptoms, nonspecific signs and symptoms of illness, autoimmune and 
neurologic disorders, a variety of opportunistic infections, and several 
types of malignancy. In June, 1985, Center for Disease Control (CDC) 
defined AIDS as the presence of a reliably diagnosed opportunistic disease 
which is indicative of underlying cellular immune deficiency in a person 
with no known underlying cause for reduced resistance, with a concurrent 
positive serologic or virologic test for HIV.2 This means that the clinical 
diagnosis of AIDS is at a point in the disease process when the HIV has 
caused severe symptomology. The most common presenting opportunistic 
infection in AIDS is Pneumocystis carinii pneumonia(58 percent). 2 
Kaposi's sarcoma, a malignancy of the skin or conjunctiva, is present in 
18 percent of the AIDS patients. Some of the other more common 
opportunistic infections seen in AIDS patients are: Toxoplasma gondii 
encephalitis or disseminated infection, Cryptosporidjum enteritis, Candida 
esophagitis or disseminated infection, Histoplasma capsulatum, 
Mycobacterium avjum-intracellulare disseminated infection, 
Mycobacterium tuberculosis disseminated infection, cytomegalovirus 
retinitis and disseminated infection, herpes simplex esophagitis and 
mucocutaneous lesions, varicella zoster virus disseminated infection, 
primary brain lymphoma(undifferentiated non-Hodgkin's and 
Burkitt's-like), and lymphocytic interstitial pneumonitis. Before the HIV 
infection has reached the stage of allowing opportunistic disease to 
occur, two preliminary stages are manifested. The earliest is the change 
in the person's immune status from seronegative to seropositive for the 
AIDS virus. These people have antibodies to the HIV, which are detectable 
with the Enzyme-Linked lmmunosorbant Assay (ELISA). Once someone has 
converted to seropositivity, the person may feel healthy, but s/he is 
infectious and most likely unaware of his/her infectious state.3 
The second stage of infection with the HIV is called AIDS Related 
Complex (ARC). A person who is seropositive for antibodies to HIV, is 
diagnosed as having ARC when s/he is from a high risk category 
(homo/bisexual male, intravenous( IV) drug abuser, hemophiliac 1) and has 
had one or more of the following symptoms for more than three months: 
fever and night sweats, persistent lymphadenopathy, chronic diarrhea, and 
lor an unexplained autoimmune condition.4 
TABLE ONE: Current and Future Predictions of the Spread of the AIDS Virus 
cumulative reported 
active AIDS cases 
(sinceJan. 1981) 
as of Jan. 19871 29,435* 
projected figures 
for Jan. 1991 5 294,350 
cumulative number of 
deaths due AIDS patients 
to H IV who are alive 
16,418 12,601 
164,180 126,010 











Table One lists the current number of reported active AIDS cases since 
1981, the number of people who currently have ARC and are HIV positive, 
and the future predictions of the spread of the HIV. It is currently 
estimated that approximately 45 percent of HIV positive individuals will 
go on to either develope ARC and/or AIDS.6 
To test for the presence of the antibody to HIV in donated blood and 
plasma an ELISA test is utilized. The American Red Cross, the Council of 
Community Blood Centers , and the American Association of Blood Banks 
found that in a given month, approximately 0.89 percent of the units of 
blood were initially reactive using the ELISA. 2 Because the ELISA reacts 
when antibodies to HIV are detected, and not to the virus itself, the 
reliability of the ELISA test does not rule out the possibility of some AIDS 
infected blood being utilized. This can occur when the infected donor is 
unable to produce any antibodies to HIV, produces too few antibodies to be 
detected on the ELISA, or donates infectious blood prior to his body 
developing antibodies to HIV(it may take two weeks to six months to 
develop antibodies to HIV.7) Currently this problem is being handled by 
discouraging high risk groups from donating blood.8 
The projected number of infected/infective individuals demonstrates 
the fact that the practitioner will be seeing patients that have AIDS,ARC 
or who are knowingly or unknowningly carrying antibodies to HIV. In a 
recent issue of the Journal of the American Optometric Association, it 
was stated that practitioners in areas where a high percentage of AIDS 
cases have been reported, could conceivably examine an HIV infected 
person once in every 200 patient encounters. 9 A report by the CDC found 
serum antibody prevalence to HIV in San Francisco area homosexuals to 
have increased from 1 percent in 1978, to 25 percent in 1980, to 65 
percent in 1984.10 Of the group tested in 1984, 55 percent of men had no 
symptoms. Also in New York City, 87 percent of heavy IV drug users tested 




AIDS Cases (adults only) By Risk Factor Combinations 1 
RISK FACTORS 
Homo/Bisexual Male 
NUMBER OF PERSONS 
18,537 
lntravenous(IV) Drug Abuse 4,448 
Homo/Bisexual Male w/hemophil ia 2,116 
Heterosexual Contact w/AIDS pt. 1,052 
Undetermined* 915 
Transfusion of Contam. Blood/Plasma 537 
Homo/Bisexual Male w!Transfusions 350 
IV Drug Abuse & Heterosex. Contact 306 
IV Drug Abuse & Blood Transfusion 153 
Bisexual Male w!Hete rosexual Contact 148 
Hemophilia/Coagulation Disorder 143 
Hemophilia & Blood Transfusion 104 
Homo/Bisexual Male & IV Drug & Bid Trans81 
Heterosexual Contact & Bid. Trans. 49 



















*includes patients on whom risk informaiion is incomplete(due to death or loss to follow up.) 
Table Two lists the cumulative AIDS cases to date by risk factor 
combinations, showing the two highest risk factors(bi/homosexual male, 
IV Drug Abuse) comprise 79.2% of the total AIDS cases. 
In terms of the reported AIDS infection via heterosexual contact, 
male-to-female sexual transmission is the most prevalent mode of HIV 
transmission. However, indications that female-to-male sexual 
transmission of HIV infection occurs via female prostitutes are currently 
being studied. Attempts to isolate the virus from cervical and vaginal 
secretions are in progress. In several preliminary studies, in various 
cities, between 5% to 40% of prostitutes had detectable HIV antibodies.11 
Researchers at the Pasteur Institute in Paris identified the causative 
agent of AI OS in 1983 and called it LAV(Iymphadenopathy-associated 
virus). The American researchers, led by Robert Gallo at the National 
Cancer Institute found his version of the AIDS virus in 1984 and named it 
HTLV-III(human T-lymphotropic/leukemia virus Type-Ill). Both Gallo and 
the French researchers think that their viruses are almost identical, but 
both insist on using their own designated names for the virus. 12 
Although direct comparative results have not been published; because 
HTLV-111 and LAV have the same apppearance by electron microscopy, 
attack the same cells, and-when isolated from American AIDS patients-
were immunologically indistinguishable, HTLV-111 and LAV are likely to be 
the same virus.1 0 In the summer of 1986 in Paris, France, in order to 
reduce variances in the virus' nomenclature, a committee of AIDS 
researchers recommended the use of Human Immunodeficiency Virus(HIV) 
as the term for the virus causing AI os.1 2 
Evidence is accumulating that the virus was present in Africa at least 
a decade before the first U.S. cases were detected and seems to be 
endemic in central African nations. A species of monkeys, the African 
Green, carries a virus that is very similar to the HIV and is called the 
Simian T-Lymphotropic Virus(STLV-111). One-half to two-thirds of the 
African Green monkeys are infected with STLV-111, and this virus may have 
been passed into humans via animal bites and the practice of Africans 
eating the green monkeys. It is further hypothesized that the virus got 
from Africa to the U.S. via American homosexual men vacationing in Haiti, 
a country with many African immigrants and an extremely high number 
of AI OS cases per capita.1 3 
Infection with the HIV causes a collapse of the immune defenses in the 
AIDS patient by reducing the number and changing the function of the T4 
lymphocytes, an important type of cell in the immune system. 
One type of white blood cell called lymphocytes, fall into two categories: 
the 8-cells and the T-cells. 8-cells are the source of antibodies(proteins 
which bind to other molecules foreign to the body and known as 
antigens.) When a 8-cell recognizes an antigen, the 8-cell becomes 
activated and produces antibody molecules that are specific for the 
antigens. When a T-lymphocyte recognizes an antigen, it performs a 
function which is dependent upon the T-lymphocyte's type. The cytotoxic 
T-cells destroy infected, foreign or malignant cells by disrupting(lysing) 
their cell membranes. The inducer T-cell, triggers the maturation of 
T-lymphocytes into functionally distinct cells. Helper T-cells trigger the 
initiation and expansion of the immune reaction of the other T -cells and 
most 8-cells. Helper T-cells enable cytotoxic T-lymphocytes to destroy 
cells containing the antigen and they allow 8-lymphocytes to secrete the 
appropriate antibodies. The fourth kind of T-cells, suppressor T-cells, 
dampen the immune response of 8 and T -cells by shutting down the 
immune system several weeks after they've been activated. These four 
types of T-cells are placed into two categories on the basis of their 
biochemical surface markers: the T4 cell category, which the HIV infects, 
consists of the T-Helper cells and T-lnducer cells. The second category, 
the T8 category, includes the T-Suppressor and T-Cytotoxic cells.14 
The HIV is an envelope virus, where the core is surrounded by 
a lipid/glycoprotein capsule. 15 Upon entering the bloodstream, the HIV 
seeks out T 4 lymphocytes, matches various surface chemical markers, and 
enters the T 4 cell, shedding its protective capsule and exposing its core 
which contains RNA. 13 The AIDS virus is also a retrovirus. This means 
that the virus' genetic information is carried on RNA and utilizing a 
special enzyme, reverse transcriptase, makes a DNA copy of its RNA inside 
the host cell. The viral DNA is then able to integrate itself into the host 
cell's chromosomes in the form of a virus known as a provirus. The T 4 
cells transcribe the viral genes and make the proteins which they encode, 
thereby becoming 'factories' producing more HIV, which then bud from the 
T4 cell's surface. It has recently been discovered that HIV has a peculiar 
biological property that causes the infected T4 cell to speed up the 
reproduction of the HIV. This property is called transacting 
transcriptional regulation(TAT), and allows for an extremely efficient 
method of virus replication, which eventually induces death of the T4 
ce11. 14 
The virus can wait in T4 cells for weeks, months or even years before 
it starts to destroy the immune system. The latent period, or carrier 
state, is generally two to five years, with the active state of the virus 
often triggered by the immune system being activated in response to some 
other infection. 13 
Besides infecting T4 cells of the immune system, the virus also infects 
monocytes and macrophage cells, causing further weakening of the immune 
system. The AIDS virus disrupts the host cell membranes, eventually 
inducing several cells to fuse and form 'giant cells', which soon die. 
Ordi narily , T4 ce lls make up 60 to 70 percent of the circulating T-eal l 
po pulati on. As sho wn in the grap h bei ow, 1 4 in A IDS, the T4 
ce ll s(cons isting of T-He!per and T-lnducer cel ls) are selective ly depleted, 
wh ile the levi of T8 ce lls(co nsisting of T-Suppressor cells and 
T -Cytotoxic ceils) remains normal. 
'""' 
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8 -ceils are unable to produce suff icient quantities of specific antibodies 
to the AI OS virus, however they are able to secrete large amounts of 
nonspecific immunoglobulins. The cytotox ic T-ceil response is also 
hampered. In summary, infection of the T 4 cells with the HIV leads to a 
. 
reduction in the number of T 4 ce lls, an inabi lity of the T 4 ce lls to 
recognize antigens, and therefore results in a severe depression in the 
functional ability of the AIDS patient's immune system. This leaves the 
AIDS patient with virtually no immunological means of defense against an 
infectious agent which, in HIV uninfected people, would be easily dealt 
with by their intact immune systems.15 
In a television interview(1986), Dr. David Baltimore, a Nobel Prize 
winning professor of biology at the Massachusetts Institute of Technology, 
stated that a vaccine for the AIDS virus is not forseen for at least five 
years or more.16 With the Surgeon General's report on the predicted 
270,000 AIDS patients by 1991, and no real cure in the near future, 
Dr. Baltimore emphasized the strong need for public education. 
There are some early clinical trials which have been met with some 
success, not in killing the AIDS virus, but in prolonging the life of a 
patient with AIDS or ARC. The drug azidothymidine(AZT) has been found to 
prolong the life of an ARC patient and decrease the incidence of 
opportunistic infection. However this drug is severely debilitating to 
patients, causing anemia and toxicity to bone marrow cells. AZT does not 
kill the AIDS virus; patients taking this drug still are infected with HIV. 
The patient just has a decreased likelihood of getting a deadly 
opportunistic infection. Two other drugs, d-penicillamine and CS-85, both 
considerably less toxic than AZT, are also currently being tested. 17 
OCULAR MANIFESTATIONS of AIDS 
The incidence of ocular manifestations of the AIDS virus is between 40 
and 94 percent. 1 8 The most common manifestations are retinal 
microvasculopathy leading to cotton-wool spots and hemorrhages, 
cytomegalovirus(CMV) retinopathy, Kaposi's sarcoma, cranial nerve 
palsies, herpes zoster ophthalmicus, papilledema, toxoplasmic 
retinochoroiditis, Mycobacterium avjum-intracellulare infection, and 
corneal ulcers caused by Candida albjcans. 
Cotton-Wool Spots 
Cotton-wool spots are the most common ocular lesions in patients with 
AIDS.18 One study of AIDS patients at UCLA found that cotton-wool 
spots were present in 53 percent of the patients, and usually were 
manifested six months after generalized lymphadenopathy was noted.1 9 
One theory on the mechanism of the AIDS-related microvasculopathy which 
causes the cotton-wool spots is that the viral antigen/antibody complex 
becomes embedded in the arterial wall, occluding the vessel and causing 
focal retinal ischemia. 18 The retinal ischemia causes a stasis in 
axoplasmic flow, resulting in a microscopic swelling of the nerve fiber 
layer and ophthalmoscopically visible retinal edema which is the 
cotton-wool spot. 
In AIDS patients cotton-wool spots occur in the superficial retina near 
the optic nerve head, and may obscure the view of retinal vessels on 
ophthalmoscopy. 4 The cotton-wool spots are asymptomatic and transient 
in nature, developing and regressing within four to six weeks. 
Cotton-wool spots are occassionally seen in patients with AIDS-Related 
Complex(ARC), but it is currently unknown if the presence of cotton-wool 
spots is predictive of the patient going on to develop the full AIDS 
illness. 18 
Retinal Hemorrhages 
The retinal microvasculopathy that caused the cotton-wool spots can 
be found in 89-100 percent of AIDS patients. 18 This microvasculopathy of 
occluded vessel lumens, swollen endothelial cells, thickened basal laminae 
and degenerating pericytes can lead to retinal hemorrhages.4 
In the UCLA study 19 retinal hemorrhages were found to occur in 27 
percent of the AIDS patients, presenting as punctate or flame-shaped 
hemorrhages in the posterior fundus. In 10 percent of the patients the 
hemorrhages had white central areas(Roth spots). Alterations in the 
retinal microvascularization may affect optic nerve vessels as well as 
the retinal, causing ischemic optic neuropathy, where the nerve head 
appears swollen and pale. Visual field changes relative to the location of 
the ischemic optic neuropathy can occur. 
Cytomegaloyjrus(CMV) Retinopathy 
Cytomegalovirus retinitis is the only common infection of the eye in 
patients with AIDS. In one study by Holland et al, 32 percent of patients 
had CMV retinopathy.19 Although CMV retinopathy usually manifests itself 
in extremely debilitated AIDS patients, CMV retinopathy is estimated to be 
the presenting ocular sign in five percent of AIDS cases.20 
CMV retinitis is a necrotizing infection, leading to full thickness 
atrophic destruction of the retina. The patient may be ill with 
disseminated CMV infection or the patient may be asymptomatic. 21 The 
CMV retinopathy is often preceded by cotton-wool spots, which do not 
always occur where the CMV retinopathy will develop.4 The earliest sign 
of CMV retinitis is white granular patches which may be unilateral or 
bilateral. The lesions will have irregular, feathered borders which become 
necrotic. The necrosis may involve all layers of the retina including the 
RPE. Sheathing of the retinal vessels and intraretinal hemorrhages are 
signs characteristic of this infection. 21 The retinal infection usually 
starts in the posterior pole next to the major vascular arcades, but may 
develop first in the peripheral retina. Choroidal inflammation, serous 
retinal detachment, exudative and rhegmatogenous retinal detachment can 
result from the retinitis. The retinal tears may be hidden by extensive 
retinal necrosis and mild vitreal haze. The optic nerve head may appear 
normal or edematous in the early stages of the retinitis and necrotic in 
the final stages of the retinopathy. Toxoplasmic retinitis may seem 
similar to CMV retinitis, however toxoplasmic infection tends to occur in 
patients who are not immuno-compromised, be posterior in location, 
centered around old scars and accompanied by vitritis. The anterior 
segment changes may include flare, cells and/or multiple small keratic 
precipitates on the cornea.22 
CMV retinopathy is progressive and may lead to total loss of vision. 
Steroid usage is contraindicated in the treatment of the AIDS patient due 
to the possibility of the immunosuppressive drug increasing the retinal 
necrosis. CMV retinopathy is a poor prognostic sign. In one study, no 
patient survived longer than six weeks after the development of the CMV 
retinitis. 19 Although several drugs have been found to halt the spread of 
the CMV retinopathy, none can eradicate the infection. If an optometrist 
suspects that a patient is manifesting a sign of CMV retinopathy, the 
patient should be referred to a retinal specialist with a note that AIDS 
must be ruled out. 
In a case study a white, homosexual male(L.S.) presented at the UCSF 
Francis I. Proctor Foundation complaining of decreased vision in his left 
eye. His right eye had a cotton wool spot which later disappeared, with 
several other cotton "Yool spots appearing at later times(see Figure 
1-pictures A,B,C.) His left eye initially presented with signs of CMV 
retinitis(see Figure 2-pictures A,B,C) which progressed into more 
extensive retinal necrosis, eventually leading to retinal gliosis shortly 
before the patient died(see Figure 3-pictures A,B,C.) 
Kaposi's Sarcoma 
Kaposi's sarcoma 1 is a neoplastic vascular disorder characterized by 
multiple violaceous nodules on the skin. Kaposi's sarcoma may develop 
anywhere on the skin of the body, on the eyelids, eyelid margins, 
conjunctiva, and rarely within the orbit. 
The conjunctiva is the most common site for initial presentation of 
Kaposi's sarcoma, with approximately 17 percent of patients with Kaposi's 
sarcoma showing just conjunctival involvement23 and 24 percent showing 
conjunctival or lid lesions.19 Conjunctival Kaposi's sarcoma may appear 
as a bright red subconjunctival lesion or as a fairly discrete violaceous, 
A) L.S. November, 1985 
Cotton Wool 
B)L.S. December, 1985 
Cotton Wool 
C) L.S. January 31, 1986 
Cotton wool-sup. temp. 
All photos courtesy of J. Sheppard, M.l 
UCSF Francis I. Proctor Fo~J'ldation 
FIGURE TWO 
Left Eye 
A) L.S. November, 1985 
CMV·induced retinopathy 
B)L.S. November, 1985 
close-up of above picture 
C) L.S. December,1985 
Adv. CMV retinopathy 
f-IGUf1L l HHLL 
Lett Eye 
A) L.S. January 31,1986 
CMV-induced retinopathy 
Signs of visible sclera & 
Moderate gliosis 
B)L.S. April, 1986 
· advanced gliosis 
C) L.S. May 13, 1986 
Adv. CMV retinopathy 
with adv. gliosis 
subconjunctival mass. 18, 19(see Figure 4-pictures A and B.) These tumors 
never regress spontaneously, but slowly spread subconjunctivally. The 
conjunctival tumors rarely interfere with vision or eyelid function.2 3 
Kaposi's sarcoma of the eyelid presents differently. Purple-red nodules 
appear on the eyelids resulting in eyelid edema, entropian formation and 
trichiasis. 18 
The differential diagnosis of Kaposi's sarcoma includes inflammation 
of the conjunctiva, diffuse hemorrhage of the conjunctiva, pyogenic 
granuloma, squamos cell carcinoma, and malignant melanoma. 25 
The incidence of Kaposi's sarcoma differed among five different groups 
of AIDS patients.24 Forty six percent of patients with AIDS-related 
Kaposi's sarcoma were homo/bisexual males without intravenous(IV) drug 
use. 27.8 percent of patients with Kaposi's sarcoma were homo/bisexual 
males with IV drug use. Females with IV drug use comprised 12.5 percent, 
and heterosexual males with IV drug use comprised 3.8 percent of AIDS 
patients with Kaposi's sarcoma. It is interesting to note that the fifth 
group, comprised of 16.3 percent of AIDS patients with this condition, 
were heterosexual IV drug users. Optometrists must be alert for this 
FIGURE FOUR 
A) Adv. Kaposi's Sarcoma 
B) Same patient with 
flourescein 
All photos courtesy of J. Sheppard, M.D.-UCSF Francis I. Proctor Foundation 
condition occurring in heterosexual AIDS patients who are IV drug users. 
This study also found that in 83 percent of the patients, Kaposi's sarcoma 
appeared in the patients before an opportunistic infection was observed.24 
Simple excision or cryotherapy can be used on isolated Kaposi's 
sarcoma lesions, but when the lesions are multifocal, chemotherapy is 
used.4 
If Kaposi's sarcoma is suspected, referral to an oncologist or anterior 
segment specialist is recommended.19 
Herpes zoster ophthalmicus 
Herpes zoster ophthalmicus is usually a disease of older individuals. It 
is characterized by a vesicular rash(which usually crusts), occurring along 
the distribution of the ophthalmic division of the trigeminal nerve. 
Foreign body sensation in one eye, conjunctival injection, ciliary flush, 
cell and flare reaction, corneal punctate epithelial staining and 
subepithelial infiltrates are also associated with this condition.26 
Several studies have suggested that when a diagnosis of herpes zoster 
ophthalmicus is made in patients who are less than 45 years old, there is a 
significant probability that the patient has AIDS or ARc.26,27,281n one 
study, 27 64 percent of the patients with herpes zoster ophthalmicus who 
were under 45 years of age had characteristics that put them in the high 
risk group for developing AIDS. These patients also had the extremely low 
T·helper/suppressor cell ratio characteristic of the immune system 
deficiency of AIDS or ARC. In another study,28 61 percent of the under 45 
year old patients with herpes zoster ophthalmicus belonged to a group at 
high risk for developing AIDS or ARC. Of these AIDS·risk patients, 91 
percent had an extremely low T·helper/suppressor cell ratio and 36 
percent had generalized lymphadenopathy. Within the 2.5 year follow·up, 
21 percent of the patients in this study developed AIDS and subsequently 
died. These studies indicate that herpes zoster ophthalmicus in a young 
patient may be one of the earliest clinical markers for the immune 
deficiency caused by HIV infection. 
Treatment of herpes zoster ophthalmicus in AIDS·risk patients should 
not include systemic steroids, because of their potential for further 
immunosuppression. Topical steroids, mydriatics, topical antibiotics, 
human leukocyte interferon and certain antiviral agents(vidarabine and 
acyclovir) may be used in treatment of these patients.26 
Intracranial Disease 
Intracranial disease may cause neuro-ophthalmic signs, such as cranial 
nerve palsies and papilledema. 
Intracranial disease occurs occassionally in the immuno-compromised 
AIDS patient, with one study reporting a 3 percent incidence.1 9 Cranial 
nerve palsies may be the first manifestations of intracranial disease and 
are most probably a result of inflammation or pressure from meningitis, 
encephalitis, and/or intracranial masses. 1 8 Palsies of the third, fourth 
and sixth cranial nerves may result in severe diplopia. Careful motility 
examination should be performed in all cases of diplopia to determine 
which of the nerves are involved. Palsy of the fifth cranial nerve may 
result in decreased reflex blinking, leading to exposure keratitis and 
conjunctivitis. Palsy of the seventh nerve can result in paresis of the 
obicularis oculi, lagophthalmos and exposure problems. 
Papilledema is a manifestation of the intracranial diseases that occur 
in AI OS patients, with 14 percent of the AI OS patients in one study having 
papilledema. 29 Papilledema presents in patients as a swollen nerve head, 
with patients reporting transient obscurations in vision lasting several 
seconds and with the visual acuity normal between these episodes. 18 
AIDS patients have an increased occurrence rate of Burkitt's lymphoma, 
a rare form of cancer causing intraorbital masses. Burkitt's lymphoma 
may also damage extraocular muscles, cranial nerves and the optic nerve, 
resulting in diplopia and papilledema. Eyelid swelling, proptosis and 
tenderness may be signs of this problem. 
Any signs or symptoms of these neurological problems, especially with 
fairly sudden onset, requires a referral to a neuro-ophthalmologist or 
neurologist for a computerized tomography(CT) scan to rule out 
intracranial mass lesions. 
Mycobacterium avjum-jntracellulare infection 
Mycobacterium avium-intracellulare infections, which are rare in the 
average population, are seen in increased numbers in AIDS patients. 
Holland and associated reported that six percent of the AIDS patients they 
studied showed signs of Mycobacterium avium-intracellulare infection , 19 
and another study reported that three percent of AIDS patients studied 
manifested signs of this infection.29 Retinal and choroidal granulomas 
located near the area of hemorrhagic retinal detachments in patients with 
CMV retinopathy were the major clinical manifestations of M..... 
aviu m-i ntracellu I are infection.1 9 
Toxoplasmic Retinochoroiditis 
Toxoplasma infection of the eye in the AIDS patient is an occassional 
occurrence. Ocular involvement from Toxoplasma gondii infection in both 
the AIDS patient and non-AIDS patient presents as a focal or multifocal, 
yellow-white hazy retinochoroiditis, with the active lesion seen at the 
border of an old inactive scar and with vitreous inflammation overlying 
the active lesion. 30 Ocular toxoplasmosis accounts for less than three 
percent of ocular infections in AIDS patients. However, intracranial 
toxoplasmosis is the most common opportunistic infection of the central 
nervous system in AIDS patients.18 
One AIDS patient who presented with ocular toxoplasmosis had 
uniocular confluent pat,ches of yellow-white necrotic retinal tissue that 
covered most of the post-equatorial retina and also a marked 
vitritis. Because of this patient's known poor health status, acute retinal 
necrosis was ruled out, since, by definition, this occurs in systemically 
healthy patients. Cytomegalovirus infection of the retina was ruled out 
because the marked vitritis is not usually present in CMV infection.30 
Also, ocular toxoplasmosis does not have the grainy, hemorrhagic 
appearance seen in the viral infection, nor does toxoplasmosis spread like 
CMV retinopathy .18 Toxoplasmosis should be suspected when any retinal 
lesion not characteristic of CMV retinopathy is seen in an AIDS patient. 
Candida albjcans 
Candida albicans is an opportunistic yeast, infecting individuals with 
depressed immune function. Mucocutaneous candidiasis in has a high 
incidence of occurrence in AIDS patients, however, intraocular Candida 
infections occur infrequently in these patients. 1 8 Candid a 
chorioretinitis resembles cotton-wool spots, except that Candida lesions 
have an associated vitreous haze of inflammatory cells and enlarge over 
time. 18 
It was suggested by Santos et al3 1 that mycotic corneal ulcers may 
result from immunological abnormalities secondary to HIV infection. This 
suggestion is based on a patient who was referred to the UC San Francisco 
Ophthalmology Research Center, with a Candida albicans corneal ulcer in 
one eye, and after treatment for the initially presenting eye, the patient 
went on to later develop a C. albicans ulcer in the other eye. Because this 
patient was an intravenous drug user and homosexual, the status of his 
immune system was monitored. Intravenous drug abuse is a known risk 
factor for candidemia. Also, this patient did test positive for antibodies 
to HIV and had a low helper/suppressor T-cell ratio. Therefore, 
asymptomatic HIV infected individuals seem to have a greater 
predisposition to Candida albicans corneal ulcers. 
PREVENTION of TRANSMISSION 
The CDC reported that three-quarters of all AIDS cases have been 
reported by only 280 of the more than 6,000 acute-care hospitals in the 
United States.3 2 A recent issue of the Morbidity and Mortality Weekly 
Report stated that from January 1, 1986 to mid-April of 1986, 3,854 new 
cases of AIDS were reported nationwide; during that same time period in 
1987, the number of AIDS cases reported was 6,022.33 From these 
statistics, it can be inferred that optometrists in high-risk areas of the 
country will have patients who are infected with the AIDS virus. Many of 
the infected persons will be asymptomatic. 
The presence of the HIV in the tears of AIDS patients but not in tears 
of a patient with ARC has been confirmed. 3 4 This study, utilizing 
Schirmer's filter paper strips, obtained tear samples from six AIDS 
patients and found that the tears of three of the six patients had 
low-levels of both reverse transcriptase and AIDS viral proteins, and one 
of the six patients had a high level of positive detection of reverse 
transcriptase and the AIDS virus. The other two AIDS patients and the 
patient with ARC had no clinical signs of the AIDS virus in their tears. 
HIV was also isolated from a conjunctival epithelial cell scraping of a 
33-year-old womari with AIDS.35 Her only known exposure was a sexual 
contact with a bisexual. She had a history of opportunistic infections, but 
no ocular complaints. 
The cornea also can contain HIV. Corneoscleral tissue from a donor had 
reverse transcriptase activity indicative of the presence of Hlv.36 The 
presence of HIV in the central cornea of the left eye, and central and 
limbal areas of the right cornea were confirmed by the detection of HIV 
specific viral proteins. The donor did test positive for the serum antibody 
to HIV, but had no overt clinical signs of AIDS. Another study suggests 
that the HIV may be common in the corneas of infected individuals, many 
of whom may be asymptomatic.37 This study found that the HIV was 
detected in two of three corneas of HIV-infected patients tested. 
Corneal transplantation has not been implicated in the transmission of 
AIDS. However, if a patient needs to be referred for corneal graft surgery, 
the patient should know if the eye bank providing the donor corneas 
screens donors for the presence of HIV. Corneal surgeons strongly prefer 
to use tissue from an HIV-negative donor than an unscreened donor, and 
eye banks are in the process of setting up appropriate screening 
programs.38 
Contact lenses of HIV infected individuals can contain the HIV. 39 
Three patients who had ARC and three patients who had AIDS(five men and 
one woman} wore high-water(70% water, 30% Lidofilcon A} contact lenses 
for 14 to 16 hours. After the lenses were removed, one lens was 
immediately cultured from each patient and the other was placed in saline 
solution, and the saline was processed for the presence of the HIV. One 
patient with AIDS was unable to complete the study because of a dry eye 
syndrome. All three of the patients with ARC had detectable HIV in the 
contact lens . One patient with AIDS and one with ARC had detectable HIV 
in the saline solution into which the other contact lens had been placed. 
Even though the AIDS virus has been isolated from the tears, cornea, 
conjunctiva and contact lenses of AIDS patients, there have been no 
studies which document the transmission of HIV from these patients to 
seronegative individuals through contact with their eyes, tears or contact 
lenses. 
The conjunctiva and corneal epithelia are both squamous and readily 
desquamate upon mild irritation. 3 5 Some of the procedures carrying 
increased risks of coming into contact with the AIDS virus in HIV infected 
patients include contact lens fitting, contact tonometry, foreign body 
removal, instillation of staining fluids, irrigation, Schirmer testing, 
cornea sensitivity measurement(aesthesiometry), Jones test for lacrimal 
drainage, instillation of eyedrops, lid eversion, palpation and general 
contact with tears.40 
Even though contact lenses have not served as an avenue of 
transmission for HIV, they must be disinfected between patients, as a 
study found that HIV is not killed after 10 days of air drying at room 
temperature. 41 Early studies recommended that trial hard, soft and RGP 
lenses should be disinfected with a hydrogen peroxide contact lens 
disinfecting system currently approved for soft lenses, or with the 
standard heat disinfection regimen(78-80 degrees Celcius for 10 minutes) 
on soft lenses and hard lenses which can be safely heat-treated.32,41-43 
A more recent study on the safe disinfection of HIV-contaminated 
contact lenses found that several contact lens cleaning solutions were 
effective against HIV.44 A total of 26 lenses in a mixed variety of PMMA, 
RGP, and low, medium and high water content soft contact lenses(made by 
a wide variety of manufacturers) were infected with HIV. On the PMMA 
and rigid gas permeable contact lenses two drops of the Boston cleaner 
were rubbed(gloves were worn) for 30 to 60 seconds on both sides of the 
lenses, which were then rinsed for five seconds with a sterile, isotonic 
saline(Lens Plus). On the low(37 .5-43o/o) soft lenses, Pliagel(made by 
CooperVision Pharmaceuticals) was used in the same manner. 
Miraflow(made by CooperVision Pharmaceuticals) was used on the 
medium(55°/o) water content and high(70-79%) water content soft lenses. 
Subsequent to the use of these cleaning soutions, several of the lenses 
were placed in disinfecting and/or conditioning solutions for varying 
amounts of time. The contact lenses were all kept in culture flasks and 
checked at one month for the presence of HIV. All of the lenses upon which 
cleaning solutions had been utilized tested negative for the presence of 
HIV, regardless of whether or not disinfecting or conditiong solutions had 
also been utilized. It is important to note that the contact lenses utilized 
as a positive control(either not cleaned or rinsed with sterile, isotonic 
saline and then incubated) still tested positive for the reverse 
transcriptase activity characteristic of the AIDS virus at the end of the 
experiment. The contact lenses which were used in this study had never 
been in a human eye, ; since the researchers were trying to mimic the 
normally deposit-free state of a contact lens set used for trial fitting. 
This study indicates that commercially available contact lens cleaning 
solutions can disinfect contact lenses contaminated with HIV. 
Because contact tonometers come in direct contact with the eye, the 
probe must be disinfected after each use. Several groups of researchers 
recommend a 5-to-1 0-minute exposure to a fresh solution of 3% hydrogen 
peroxide, or a fresh solution of 1 :10 dilution of common household 
bleach(sodium hypochlorate,) or 70o/o ethanol, or 70% isopropanol. These 
disinfectants are also recommended for the Schiotz tonometer. The probe 
should be thoroughly rinsed in tap water and dried before reuse.42,43,45 
According to the Haag-Streit Company many of these chemical treatments 
will destroy the probe after consistent use.46 The Haag-Streit Company 
markets PANTASEPT for disinfection of applanation tonometer probes. The 
solution, when diluted to the proper concentration, contains a variety of 
disinfectants which most likely will kill the Hlv.4 0 This, however, 
remains to be proven. A study testing the effect of various probe cleaning 
solutions has found that bleach causes the least damage to the probe.46 
Tonometry may also be performed safely with a MacKay-Marg instrument 
in which the sleeve is discarded after each use.35 
Foreign body removal may present a danger to the optometrist in case 
of accidental self-injury. Sharp items should be considered as potentially 
infective and disposed of in puncture resistant containers or safely 
disinfected. The risk of HIV infection following a needlestick-type injury 
involving an HIV-infected source patient is less_than_j~~_g ____ _ 
For a general office safety procedure, handwashing after a procedure 
involving contact with tears and between patients is recommended. 
Gloves should be worn when there are cuts, scratches or dermatologic 
lesions on the hands.42,45 General working surfaces which are potentially 
contaminated can be disinfected by wiping with a dilute(0.2°/o or greater) 
household bleach solution or with an alcohol solution(30% or greater). 
70-80% alcohol is the optimum concentration for virtually instantaneously 
killing the AIDS virus.40 A study found that the HIV was not inactivated 
by ultraviolet radiation in doses which were much higher than those used 
in hospitals and labs. 4 7 
In summary, if a patient is suspected of being infected with the AIDS 
virus, careful questions regarding any symptoms such as fever, malaise or 
lymphadenopathy should be asked, and possibly a referral for a blood test 
to rule out AIDS. 
The risk of transmission of the virus from AIDS patients to health care 
workers is considered minimal. In one study, a total of 531 health care 
workers were evaluated.48 One hundred-fifty of these workers reported 
exposure to HIV that was a result of injury by needle, scalpel or other 
sharp object that had been contaminated with blood or body fluid from an 
AIDS patient, or mucous membrane exposure(contamination of mouth, nasal 
or conjunctival membrane by blood or urine of an AIDS patient.) Of these 
150 health care workers, none had serological evidence of HIV infection 6 
to 46 months following exposure. However, as has recently been 
publicized, non-needle-stick exposures to blood from infected patients is 
a viable mode of viral transmission. CDC states that three health care 
workers have become seropositive for HIV following exposure to infected 
blood. 49 Health Care Worker 1 had chapped hands, and the duration of 
contact with the blood of the patient experiencing a cardiac arrest may 
have been as long as 20 minutes. Health Care Worker 2 sustained 
contamination of oral mucous membranes and a needle-scratch 
from an IV drug abuser of unknown HIV-infection status. Health Care 
Worker 3 had a history of dermatitis involving an ear. Health Care Worker 
1 and 3 were not wearing gloves, and Health Care Worker 2 had 
contaminated blood on her face and mouth. This brings the total number of 
health care workers who have become infected(with or without 
needlestick injury) to 9. 
Because AIDS is a deadly virus, optometrists must take the necessary 
precautions as outlined above to prevent patient to patient and/or patient 
to optometrist transmission. 
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